fda warning letters glp-1 september 2025 issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of CDER Warning Letters Jump 50%

Always seek personalized medical advice for individual healthcare decisions

The market is projected to reach USD 70.08 billion in 2025 and USD 156.71 billion by 2030, expanding at a compound annual growth rate (CAGR) of 17.46% from 2025 to 2030 (Figure 2)

It was traditionally believed that gastrointestinal symptoms were a direct outcome of a delay in gastric emptying

During your initial consultation, we review your metabolic panel, medical history, current medications, and goals

About Gastric Bypass Another obesity treatment option is gastric bypass.[3] Gastric bypass, also known as Roux-en-Y gastric bypass, was developed in the 1960s as a procedural operation for peptic ulcer disease

Which specific weight loss medications are covered under your plans